185 related articles for article (PubMed ID: 34227895)
1. Novel Post-Translational Modifications and Molecular Substrates in Glioma Identified by Bioinformatics.
Rex DAB; Arun Kumar ST; Rai AB; Kotimoole CN; Modi PK; Prasad TSK
OMICS; 2021 Jul; 25(7):463-473. PubMed ID: 34227895
[TBL] [Abstract][Full Text] [Related]
2. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
[TBL] [Abstract][Full Text] [Related]
3. Post-translational modifications of pancreatic fluid proteins collected via the endoscopic pancreatic function test (ePFT).
Paulo JA; Kadiyala V; Brizard S; Banks PA; Steen H; Conwell DL
J Proteomics; 2013 Oct; 92():216-27. PubMed ID: 23500127
[TBL] [Abstract][Full Text] [Related]
4. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers.
Zhu G; Jin L; Sun W; Wang S; Liu N
Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188735. PubMed ID: 35577141
[TBL] [Abstract][Full Text] [Related]
5. Glioma and post-translational modifications: A complex relationship.
Pienkowski T; Kowalczyk T; Cysewski D; Kretowski A; Ciborowski M
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189009. PubMed ID: 37913943
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis tools for post-translational modification: a post-translational modification database for analysis of proteins and metabolic pathways.
Cruz ER; Nguyen H; Nguyen T; Wallace IS
Plant J; 2019 Sep; 99(5):1003-1013. PubMed ID: 31034103
[TBL] [Abstract][Full Text] [Related]
7. [Post-translational modification (PTM) bioinformatics in China: progresses and perspectives].
Liu ZX; Cai YD; Guo XJ; Li A; Li TT; Qiu JD; Ren J; Shi SP; Song JN; Wang MH; Xie L; Xue Y; Zhang ZD; Zhao XM
Yi Chuan; 2015 Jul; 37(7):621-34. PubMed ID: 26351162
[TBL] [Abstract][Full Text] [Related]
8. Post-translational modifications of proteins in cardiovascular diseases examined by proteomic approaches.
Stastna M
FEBS J; 2024 Mar; ():. PubMed ID: 38440918
[TBL] [Abstract][Full Text] [Related]
9. Proteomic characterization of post-translational modifications in drug discovery.
Zhai LH; Chen KF; Hao BB; Tan MJ
Acta Pharmacol Sin; 2022 Dec; 43(12):3112-3129. PubMed ID: 36372853
[TBL] [Abstract][Full Text] [Related]
10. Mining proteomics data to extract post-translational modifications associated with gastric cancer.
Ramesh P; Behera SK; Kotimoole CN; Mohanty V; Raju R; Prasad TSK; Codi JAK
Amino Acids; 2023 Aug; 55(8):993-1001. PubMed ID: 37311859
[TBL] [Abstract][Full Text] [Related]
11. Mapping Post-Translational Modifications in Brain Regions in Alzheimer's Disease Using Proteomics Data Mining.
Deolankar SC; Patil AH; Rex DAB; Subba P; Mahadevan A; Prasad TSK
OMICS; 2021 Aug; 25(8):525-536. PubMed ID: 34255573
[TBL] [Abstract][Full Text] [Related]
12. Maximizing Depth of PTM Coverage: Generating Robust MS Datasets for Computational Prediction Modeling.
Iannetta AA; Hicks LM
Methods Mol Biol; 2022; 2499():1-41. PubMed ID: 35696073
[TBL] [Abstract][Full Text] [Related]
13. Computational refinement of post-translational modifications predicted from tandem mass spectrometry.
Chung C; Liu J; Emili A; Frey BJ
Bioinformatics; 2011 Mar; 27(6):797-806. PubMed ID: 21258065
[TBL] [Abstract][Full Text] [Related]
14. Decoding Post-Translational Modification Crosstalk With Proteomics.
Leutert M; Entwisle SW; Villén J
Mol Cell Proteomics; 2021; 20():100129. PubMed ID: 34339852
[TBL] [Abstract][Full Text] [Related]
15. Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme.
Kumari S; Gupta R; Ambasta RK; Kumar P
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188999. PubMed ID: 37858622
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics bridging proteomics along metabolites/oncometabolites and protein modifications: Paving the way toward integrative multiomics.
Nalbantoglu S; Karadag A
J Pharm Biomed Anal; 2021 May; 199():114031. PubMed ID: 33857836
[TBL] [Abstract][Full Text] [Related]
17. Impact of Nonsynonymous Single-Nucleotide Variations on Post-Translational Modification Sites in Human Proteins.
Gulzar N; Dingerdissen H; Yan C; Mazumder R
Methods Mol Biol; 2017; 1558():159-190. PubMed ID: 28150238
[TBL] [Abstract][Full Text] [Related]
18. Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques.
Zhao Y; Jensen ON
Proteomics; 2009 Oct; 9(20):4632-41. PubMed ID: 19743430
[TBL] [Abstract][Full Text] [Related]
19. A Curated Resource for Phosphosite-specific Signature Analysis.
Krug K; Mertins P; Zhang B; Hornbeck P; Raju R; Ahmad R; Szucs M; Mundt F; Forestier D; Jane-Valbuena J; Keshishian H; Gillette MA; Tamayo P; Mesirov JP; Jaffe JD; Carr SA; Mani DR
Mol Cell Proteomics; 2019 Mar; 18(3):576-593. PubMed ID: 30563849
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
Li J; Zhan X
Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
